Bio-Rad Laboratories Inc. Class A (BIO) Peer Comparison

$390.21

$1.57 (0.40%)

As on 27-Aug-2026 14:45EDT

Market cap

$10,066 Mln

Revenue (TTM)

$2,589 Mln

P/E Ratio

44.4

P/B Ratio

1.4

Div. Yield

0 %

Edit

	Bio-Rad Laboratories Inc. Class A (BIO)	Koninklijke Philips N.V. NY Registry Shares - ADR	Baxter International (BAX)	Align Technology (ALGN)	Globus Medical (GMED)
Market cap ($ Mln)	10,066	26,879	13,654	11,548	11,502
Revenue ($ Mln)	2,589	17,664	11,470	4,140	3,145
Net Profit ($ Mln)	222.40	1,114.00	-1,063.00	413.58	535.46
Net Margin (%)	8.59	6.31	-9.27	9.99	17.03
RoE (%)	3.04	9.93	-17.24	9.99	11.46
Price to Earnings	44.45	20.99	--	27.60	22.54
Price-To-Book	1.40	2.04	2.22	2.67	2.49

Income Statement ($ Mln)

	Bio-Rad Laboratories Inc. Class A (BIO)	Koninklijke Philips N.V. NY Registry Shares - ADR	Baxter International (BAX)	Align Technology (ALGN)	Globus Medical (GMED)
Operating Revenue	2,589.30	17,664.00	11,470.00	4,139.53	3,144.90
Cost of Revenue	1,245.50	9,551.00	8,020.00	1,387.59	989.14
Gross Profit	1,343.60	8,058.00	3,379.00	2,756.90	1,981.10
Operating Expenses	1,108.90	6,392.00	3,724.00	2,200.16	1,504.66
Operating Profit (EBIT)	235.00	1,721.00	-274.00	551.86	652.69
Other Income	0.00	0.00	0.00	0.00	0.00
Profit before Tax	350.40	1,477.00	-483.00	568.91	664.95
Provision for Tax	128.00	364.00	485.00	155.33	129.49
Profit after Tax (Net Income)	222.40	1,114.00	-1,063.00	413.58	535.46
Minority Interest	0.00	-2.00	0.00	0.00	0.00
Consolidated Profit	378.10	579.00	-1,174.00	0.00	0.00

	Bio-Rad Laboratories Inc. Class A (BIO)	Koninklijke Philips N.V. NY Registry Shares - ADR	Baxter International (BAX)	Align Technology (ALGN)	Globus Medical (GMED)
Shareholder's Funds	7,173.90	11,447.00	6,206.00	4,232.45	4,768.60
Minority Interest	0.00	-2.00	0.00	0.00	0.00
Non-Current Liabilities	2,116.80	7,802.00	10,021.00	276.53	240.31
Current Liabilities	961.30	7,423.00	3,591.00	1,908.60	479.35
Total Liabilities	10,576.50	26,944.00	20,055.00	6,233.69	5,302.76

	Bio-Rad Laboratories Inc. Class A (BIO)	Koninklijke Philips N.V. NY Registry Shares - ADR	Baxter International (BAX)	Align Technology (ALGN)	Globus Medical (GMED)
Non-Current Assets	7,231.50	17,371.00	12,802.00	3,754.53	3,272.75
Current Assets	3,020.50	9,330.00	6,989.00	2,663.05	2,215.51
Total Assets	10,576.50	26,944.00	20,055.00	6,233.69	5,302.76
Total Debt*	1,203.70	7,465.00	9,667.00	120.84	111.19
Net Current Assets	2,059.20	1,907.00	3,398.00	754.45	1,736.17

	Bio-Rad Laboratories Inc. Class A (BIO)	Koninklijke Philips N.V. NY Registry Shares - ADR	Baxter International (BAX)	Align Technology (ALGN)	Globus Medical (GMED)
Cash From Operating Activities	532.20	1,162.00	845.00	593.22	753.45
Cash Flow from Investing Activities	-189.70	-737.00	2,841.00	-112.45	-355.01
Cash from Financing Activities	-283.20	107.00	-4,216.00	-464.58	-679.16
Net Cash Inflow / Outflow	--	--	--	--	--

	Bio-Rad Laboratories Inc. Class A (BIO)	Koninklijke Philips N.V. NY Registry Shares - ADR	Baxter International (BAX)	Align Technology (ALGN)	Globus Medical (GMED)
ROCE (%)	8.98	4.64	-5.24	10.09	11.44
ROE (%)	3.04	9.93	-17.24	9.99	11.46
ROA (%)	2.02	3.29	-4.49	5.00	9.43
EBIT Margin (%)	-5.99	10.30	-1.77	15.19	15.11
Net Margin (%)	8.59	6.31	-9.27	9.99	17.03
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

	Bio-Rad Laboratories Inc. Class A (BIO)	Koninklijke Philips N.V. NY Registry Shares - ADR	Baxter International (BAX)	Align Technology (ALGN)	Globus Medical (GMED)
Revenue Growth (%)	1.37	-1.08	5.36	4.41	19.74
EBIT Growth (%)	-131.06	59.79	-734.38	-3.03	36.96
Net Profit Growth (%)	-30.32	587.65	-585.81	-5.49	50.14
EPS Growth (%)	-29.66	579.15	-571.39	-2.80	50.51
Book Value Growth (%)	2.19	8.94	-15.87	9.63	9.65

	Bio-Rad Laboratories Inc. Class A (BIO)	Koninklijke Philips N.V. NY Registry Shares - ADR	Baxter International (BAX)	Align Technology (ALGN)	Globus Medical (GMED)
Price / Earnings	10.77	29.23	-10.26	27.31	22.27
Price / Book Value	1.10	2.39	1.60	2.77	2.62
Dividend Yield (%)	--	--	--	--	--
EV/EBITDA	6.54	11.92	23.32	13.35	15.81
Market Cap ($ Cr)	--	--	--	--	--

	Bio-Rad Laboratories Inc. Class A (BIO)	Koninklijke Philips N.V. NY Registry Shares - ADR	Baxter International (BAX)	Align Technology (ALGN)	Globus Medical (GMED)
Debt to Equity	0.11	0.55	1.39	0.00	0.00
Short term debt to equity ratio	0.06	0.10	0.14	0.01	0.00
Current Ratio	3.14	1.26	1.95	1.40	4.62
Quick Ratio	2.33	0.82	1.32	1.28	2.93
Interest Coverage	8.18	5.06	-0.65	364.75	97.52

	Bio-Rad Laboratories Inc. Class A (BIO)	Koninklijke Philips N.V. NY Registry Shares - ADR	Baxter International (BAX)	Align Technology (ALGN)	Globus Medical (GMED)
Debtors to sales (%)	17.06	20.36	16.18	27.74	23.51
Asset Turnover	0.24	0.52	0.48	0.50	0.55
Receivable days	65.39	73.75	59.48	99.00	82.15
Inventory Days	221.09	113.36	99.33	68.68	270.47
Payable days	37.02	70.18	45.67	32.89	33.17
Cash Conversion Cycle	249.46	116.92	113.14	134.79	319.45

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.